CSE bulletin 2023-0716

Bright Minds Biosciences Inc. has consolidated its issued and outstanding common shares on the basis of one postconsolidated common share for every five preconsolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 3,772,071 common shares.

The name and symbol will not change.

Please note that all open orders will be cancelled at the close of business on July 13, 2023. Dealers are reminded to re-enter their orders taking into account the share consolidation.

Trading on a consolidated basis:  July 14, 2023

Record date:  July 17, 2023

Anticipated payment date:  July 14, 2023

Symbol:  DRUG

New Cusip No.:  10919W 40 5

New ISIN:  CA 10919W 40 5 6

Old Cusip No.:  10919W 10 8

Old ISIN:  CA 10919W 10 8 6